APA (7th ed.) Citation

Schlander, M., Dintsios, C., & Gandjour, A. (2018). Budgetary impact and cost drivers of drugs for rare and ultrarare diseases. Value in health, 21(5), . https://doi.org/10.1016/j.jval.2017.10.015

Chicago Style (17th ed.) Citation

Schlander, Michael, Charalabos-Markos Dintsios, and Afschin Gandjour. "Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases." Value in Health 21, no. 5 (2018). https://doi.org/10.1016/j.jval.2017.10.015.

MLA (9th ed.) Citation

Schlander, Michael, et al. "Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases." Value in Health, vol. 21, no. 5, 2018, https://doi.org/10.1016/j.jval.2017.10.015.